Peer Review Report For: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda [version 1; peer review: 1 approved, 1 approved with reservations]
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Hemoglobinopathies and Related Disorders
Malaria Research and Control
Blood groups and transfusion
Publication details
- Journal / source
- Wellcome Open Research
- Publication date
- 1 April 2026
- Language
- EN